[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100631528":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":26,"responsibleParty":45,"collaborators":47,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":10,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Center of New Medical Technologies","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"group with persistence of H. pylori",null,"group with metabolic syndrome and persistence of H. pylori",{"label":13,"type":10,"description":14,"interventionNames":10},"group without persistence of H. pylori","group without metabolic syndrome and persistence of H. pylori",[16,22],{"name":17,"role":18,"phone":19,"phoneExt":20,"email":21},"Evgeniya V Shrainer, PhD","CONTACT","983 300 22 05","+7","shrayner_ev@cnmt.ru",{"name":23,"role":18,"phone":24,"phoneExt":20,"email":25},"Elizaveta K Nemkova, MD","9512732447","nemkova_ek@cnmt.ru",[27],{"facility":5,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Novosibirsk","Novosibirsk Oblast","630090","Russia","RU",{"type":35,"coordinates":36},"Point",[37,38],82.93175,55.02259,{"lat":38,"lon":37},[41],{"name":42,"role":18,"phone":43,"phoneExt":20,"email":44},"Andrey V Ponomarenko, MD","9628316017","ponomarenko_av@cnmt.ru",{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[48],{"name":49,"class":6},"Novosibirsk State University","100631528","assessing-the-association-between-h-pylori-persistence-and-the-severity-of-insulin-resistance-in-patients-with-metabolic-syndrome-100631528",false,"NCT07501858","Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome","Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome Cohort Observational Study","Inclusion Criteria:\n\n* Verified MS per NCEP-ATP III criteria.\n* Ability to undergo all procedures (fasting blood draw, breath test, stool antigen, endoscopy\u002Fbiopsy, anthropometry).\n\nExclusion Criteria:\n\n* Current metabolic-influencing therapy.\n* Acute\u002Fchronic infection or autoimmune flare.\n* Interventional study participation in last 3 months.\n* Planned surgery\u002Flong hospitalization.\n* Active malignancies.\n* Severe liver\u002Fkidney failure.\n* Pregnancy\u002Flactation.\n* Gastric resection or upper GI reconstruction.\n* Type 1 diabetes.","ALL","18 Years","65 Years",{"count":61,"type":62},100,"ESTIMATED","OBSERVATIONAL","This retrospective cohort study evaluates the association between H. pylori persistence and insulin resistance severity (HOMA-IR) in 100 patients with metabolic syndrome at Novosibirsk's Center for New Medical Technologies (CNMT). Patients are divided into infected (n=50) and non-infected (n=50) groups, assessing metabolic parameters, gastro panel, and CRP. Primary endpoint: HOMA-IR differences; secondary: correlations with gastric inflammation and metabolic markers.",[66],"Metabolic Syndrome",[68,69,70,71],"insulin resistance","HOMA-IR","Helicobacter pylori","inflammation of the gastrointestinal mucosa","2026-03-24",{"date":74,"type":75},"2026-03-30","ACTUAL",{"date":77,"type":62},"2026-04-01",{"date":79,"type":62},"2028-07-01",{"name":5,"class":6},1]